Paperpal Prime Logo

FRONTIERS IN BIOSCIENCE-LANDMARK : Impact Factor & More

eISSN: 2768-6698pISSN: 2768-6701
JournalOpen Access

Key Metrics

Impact Factor
< 5
SJR
Q2Medicine (miscellaneous)
Recommended pre-submission checks
Powered by Paperpal by Editage

FRONTIERS IN BIOSCIENCE-LANDMARK Journal Specifications

Overview
Publisher IMR PRESS
Language English
Frequency Monthly
Article Processing ChargesUSD 2500
Publication Time16
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in FRONTIERS IN BIOSCIENCE-LANDMARK ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in FRONTIERS IN BIOSCIENCE-LANDMARK

The Role of Gut Microbiota in Osteoporosis Triggered by High-Fat Diets: Mechanisms and Targeted Therapeutic Strategies.
  • 28 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Integrative Bioinformatics and Experimental Validation Reveal that METTL9 Drives Lung Adenocarcinoma Progression via TGF-β/Smad-Mediated EMT Activation.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Lachnospiraceae and Its Metabolite Malate Act in Concert to Repair Gut Microbiota Imbalance and Block Colorectal Cancer Progression.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Neutrophil Extracellular Traps in Aortic and Cerebrovascular Diseases: Biomarkers, Immunomodulation, and Device-Related Strategies.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Region- and Cell-Specific Vulnerability to ROS After Global Brain Ischemia-Reperfusion Injury: Molecular and Cellular Mechanisms.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
The Role of Gut Microbiota in Osteoporosis Triggered by High-Fat Diets: Mechanisms and Targeted Therapeutic Strategies.
  • 28 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Integrative Bioinformatics and Experimental Validation Reveal that METTL9 Drives Lung Adenocarcinoma Progression via TGF-β/Smad-Mediated EMT Activation.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Lachnospiraceae and Its Metabolite Malate Act in Concert to Repair Gut Microbiota Imbalance and Block Colorectal Cancer Progression.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Neutrophil Extracellular Traps in Aortic and Cerebrovascular Diseases: Biomarkers, Immunomodulation, and Device-Related Strategies.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
Region- and Cell-Specific Vulnerability to ROS After Global Brain Ischemia-Reperfusion Injury: Molecular and Cellular Mechanisms.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)
CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation.
  • 27 Jul 2026
  • Frontiers in bioscience (Landmark edition)

FAQs on FRONTIERS IN BIOSCIENCE-LANDMARK